ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU)

Q: What does CUSIP 005083100 represent in this 13F holders report?

CUSIP 005083100 is the security identifier for ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share used to aggregate holder disclosures.

Q: How many institutions held ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share in Q1 2026?

7 institutional investors reported ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 005083100

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, par value $0.000001 per share
Shares outstanding: 23,561,857
Total 13F shares: 354
Share change: +313
Total reported value: $970
Price per share: $2.79
Number of holders: 7
Value change: +$857
Number of buys: 6

Quarterly Holders Quick Answers

What is CUSIP 005083100?
CUSIP 005083100 identifies ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 005083100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Top shareholders of ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BIOS Fund I, LP	13D/G	AARON G.L. FLETCHER	50%	10,267,232	$112,734,207	+$1,733,259	27 Jun 2025	13D/G
Aaron G.l. Fletcher	3/4/5	Director, 10%+ Owner	— mixed-class rows	10,329,768 mixed-class rows	$111,175,297	+$499,996	27 Jun 2025	3/4/5
Bios Equity COF, LP	3/4/5	Director, 10%+ Owner	— mixed-class rows	10,314,768 mixed-class rows	$111,175,297	+$499,996	27 Jun 2025	3/4/5
Leslie W. Kreis	3/4/5	Director, 10%+ Owner	— mixed-class rows	10,314,768 mixed-class rows	$111,175,297	+$499,996	27 Jun 2025	3/4/5
BIOS Capital Management, LP	13F	Company	43%	10,049,996	$61,505,976	—	31 Dec 2025	13F
Todd S. Thomson	3/4/5	Director, 10%+ Owner	— mixed-class rows	2,369,344 mixed-class rows	$16,003,463	-$1,624,000	05 Jan 2026	3/4/5
Voss Capital, LP	13F 13D/G	Company	7.7% from 13D/G	1,300,000	$7,956,000	—	31 Dec 2025	13F 13D/G
VANGUARD GROUP INC	13F	Company	2.2%	529,111	$3,238,159	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	1.8%	432,041	$2,644,091	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.88%	207,744	$1,271,393	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.43%	101,423	$620,709	—	31 Dec 2025	13F
Texas Capital Bank Wealth Management Services Inc	13F	Company	0.4%	94,592	$578,903	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.24%	56,290	$344,495	—	31 Dec 2025	13F
ROYAL BANK OF CANADA	13F	Company	0.15%	35,187	$215,000	—	31 Dec 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	30,982	$189,610	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	23,841	$145,907	—	31 Dec 2025	13F
Rock Creek Group, LP	13F	Company	0.09%	21,759	$133,165	—	31 Dec 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.09%	20,146	$123,294	—	31 Dec 2025	13F
SFMG, LLC	13F	Company	0.08%	20,000	$122,400	—	31 Dec 2025	13F
Gleason Group, Inc.	13F	Company	0.08%	19,028	$116,451	—	31 Dec 2025	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0.08%	18,518	$113,330	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.07%	16,625	$101,745	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.06%	14,946	$91,470	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.06%	13,119	$80,289	—	31 Dec 2025	13F
LPL Financial LLC	13F	Company	0.06%	12,965	$79,346	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.05%	12,565	$76,898	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	10,253	$62,748	—	31 Dec 2025	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	9,534	$58,343	—	31 Dec 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	9,309	$56,971	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	9,061	$55,454	—	31 Dec 2025	13F
ABS Direct Equity Fund LLC	13F	Company	0.03%	6,597	$40,374	—	31 Dec 2025	13F
Global Retirement Partners, LLC	13F	Company	0.03%	6,250	$38,250	—	31 Dec 2025	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	6,200	$37,944	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.02%	5,121	$31,340	—	31 Dec 2025	13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13F	Company	0.02%	4,423	$27,069	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	3,795	$23,225	—	31 Dec 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.01%	2,392	$14,639	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	1,636	$10,012	—	31 Dec 2025	13F
Legal & General Group Plc	13F	Company	0.01%	1,279	$7,828	—	31 Dec 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1,000	$6,120	—	31 Dec 2025	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	601	$3,678	—	31 Dec 2025	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0%	585	$3,580	—	31 Dec 2025	13F
Russell Investments Group, Ltd.	13F	Company	0%	487	$2,980	—	31 Dec 2025	13F
AMALGAMATED BANK	13F	Company	0%	298	$2,000	—	31 Dec 2025	13F
FMR LLC	13F	Company	0%	280	$1,714	—	31 Dec 2025	13F
CITIGROUP INC	13F	Company	0%	215	$1,316	—	31 Dec 2025	13F
Sterling Capital Management LLC	13F	Company	0%	40	$245	—	31 Dec 2025	13F
EverSource Wealth Advisors, LLC	13F	Company	0%	2	$12	—	31 Dec 2025	13F
True Wealth Design, LLC	13F	Company	0%	1	$7	—	31 Dec 2025	13F
Bios Clinical Opportunity Fund, LP	3/4/5	10%+ Owner	— class O/S missing	231,377	—	—	12 Aug 2024	3/4/5

Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) as of Q1 2026

As of 31 Mar 2026, ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 354 shares. The largest 7 holders included GAMMA Investing LLC, Sterling Capital Management LLC, True Wealth Design, LLC, Farther Finance Advisors, LLC, Root Financial Partners, LLC, IFP Advisors, Inc, and SJS Investment Consulting Inc.. This page lists 7 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-37

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.